4//SEC Filing
CHALMERS DEREK T 4
Accession 0001209191-20-034314
CIK 0001346830other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 7:53 PM ET
Size
7.0 KB
Accession
0001209191-20-034314
Insider Transaction Report
Form 4
CHALMERS DEREK T
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2020-06-03$16.01/sh−4,300$68,843→ 966,421 total - Sale
Common Stock
2020-06-01$16.00/sh−700$11,200→ 970,721 total
Footnotes (2)
- [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001166287
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 7:53 PM ET
- Size
- 7.0 KB